Log In
Print this Print this

TACE rAd-p53 artery injection

  Manage Alerts
Collapse Summary General Information
Company Shenzhen SiBiono GeneTech Co. Ltd.
DescriptionTrans-catheter chemo-embolization (TACE) plus recombinant adenoviral human p53 gene (rAd-p53)
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy
Latest Stage of DevelopmentPhase II
Standard IndicationLiver cancer
Indication DetailsTreat advanced hepatocellular carcinoma (HCC); Treat hepatocellular cancer (HCC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today